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Commentary on ‘Sebocyte
differentiation as a new target for
acne therapy: an in vivo
experience’
Alterations in sebocyte functions, referred to as dysseborrhea,
caused by changes in sebum composition and the rate of secre-
tion are characteristic features of many of the most common
and well-known skin diseases, including acne, seborrhoeic der-
matitis, atopic dermatitis, rosacea and psoriasis. According to
our current understanding, sebum plays important roles in the
formation of the cutaneous barrier, and a growing body of evi-
dence suggests that changes in sebaceous lipogenesis are disease
markers and important determinants of the pathogenic pro-
cesses.1,2 Through their special properties, sebaceous glands and
sebocytes create a specific and characteristic innate and adaptive
immune barrier and play a prominent role in the development
of the region-specific distribution observed in the diseases men-
tioned above.3 As a result, studies that are carefully investigating
sebum composition changes in these different cutaneous condi-
tions and the underlying pathogenic cellular and molecular
events may enhance our understanding of the etiopathogenesis
of a particular disease and provide novel target molecules and
treatment modalities.
Enhanced sebum secretions in the affected skin of acne
patients have been observed for decades,4 and recent studies
highlight marked composition differences compared to age-
matched control individuals.1 These investigations confirmed
that the human sebum has a special species-specific composi-
tion. Consequently, it is not possible to find suitable animal
models to study these functions, and researchers still heavily rely
on the use of in vitro cell cultures to elucidate disease pathogene-
sis. However, results that are obtained using especially immortal-
ized cells are sometimes difficult to translate to an entire
organism. These cells grow under strictly controlled environ-
mental conditions, and their specific characteristics (e.g. differ-
entiation state), which can also affect their responsiveness, may
not truly represent the features of the in vivo counterparts. As a
result, it is important to carefully monitor the properties and
functions of the in vitro model systems used.
A good example of such a careful study is in the current
JEADV issue. Ottaviani et al.5 investigated the consequences of
insulin treatment in human in vitro cultured immortalized sebo-
cytes. In their studies, the authors performed insulin treatment
in SZ95 cells exhibiting various differentiation levels, which they
achieved simply by discarding serum from the culturing media
or performing the assays in cultures representing different con-
fluency levels. They showed that low confluence and serum-free
cultures include cells representing a less differentiated state.
These sebocytes exhibited a higher sensitivity to insulin, which is
one of the important regulators of sebaceous gland activity.4 The
treated cells responded with increased lipid production and
qualitative and quantitative changes in the composition of the
secreted sebum. These changes were accompanied by increased
expression of genes playing a role in lipid homoeostasis (e.g.
SREBP1, FAS, FSDS2), in a manner similar to that observed with
acne patients. Induction of SZ95 differentiation with a chemical
(NAC-GED0507) specifically targeting PPARc6 significantly
lowered the measured effects of insulin challenge on lipogenesis.
As a proof of principle, the presented in vitro data nicely
translated to the patient level, and a gel containing 1% NAC-
GED0507 significantly reduced acne manifestations in an open-
label phase 1 clinical trial. This was accompanied by a marked
induction of sebocyte differentiation, together with a consequent
alteration of sebum composition and inflammation reduction.
These results clearly show that, apart from the well-described
role of sebocytes in the induction if innate immune and inflam-
matory events,7 their differentiation is an important factor dur-
ing acne pathogenesis. Carefully planned and evaluated in vitro
cell culture studies have a translational potential, resulting in
clinically relevant data even in the absence of more complex
model systems.
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